These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9808259)

  • 1. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
    Ninan I; Kulkarni SK
    Eur J Pharmacol; 1998 Oct; 358(2):111-6. PubMed ID: 9808259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
    Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
    Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
    Ninan I; Kulkarni SK
    Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
    Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
    J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
    O'Neill MF; Heron-Maxwell CL; Shaw G
    Pharmacol Biochem Behav; 1999 Jun; 63(2):237-43. PubMed ID: 10371652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
    Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
    Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice.
    Qi CT; Zou H; Zhang CH; Xie QL; Jin ML; Yu L
    Acta Pharmacol Sin; 2006 Nov; 27(11):1401-8. PubMed ID: 17049114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis.
    Carlsson ML
    J Neural Transm Gen Sect; 1995; 100(3):225-37. PubMed ID: 8748668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication).
    Martin P; Waters N; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1997; 104(4-5):561-4. PubMed ID: 9295186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
    Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
    Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
    Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.